FCBA Weighs In On Recusal In Myriad Gene Patent Suit

By Abigail Rubenstein (August 4, 2010, 3:26 PM EDT) -- Without endorsing either side, the Federal Circuit Bar Association has weighed in on a bid by plaintiffs fighting the patentability of human genetic material to exclude a judge, based on remarks he made at an educational conference, from an appeals panel hearing a case over Myriad Genetics Inc.'s patents.

The 2,400-member bar association stressed the importance of judicial participation in educational conferences in an amicus curiae brief filed Tuesday in the U.S. Court of Appeals for the Federal Circuit by Edward Reines of Weil Gotshal & Manges LLP and Thomas Hungar of Gibson Dunn & Crutcher LLP.

The brief highlights the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!